Atlas Trials

MILES-3: Cisplatin in Combination With Gemcitabine for Elderly Patients With Lung Cancer

Clinical trial NCT01405586 · UNKNOWN

Trial details

NCT number
NCT01405586
Sponsor
National Cancer Institute, Naples
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer MetastaticNon-small Cell Lung Cancer Stage IIIB
Start date
2011-03-01
Primary completion
2024-11-01
Enrollment
299

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.